Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 1, 2021
Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective
Cormac Kennedy, Laura McCullagh, Roisin Adams, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 2, 2008
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010
Kathleen Bennett, Zubair Kabir, Michael Barry, et al.
British Journal of Clinical Pharmacology
|
December 19, 2014
Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients
Ronan T Grimes, Kathleen Bennett, Lesley Tilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
Joy Leahy, Conor Hickey, David McConnell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2008
Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland
Lesley Tilson, Cara Usher, Karina Butler, et al.
BMC Health Services Research
|
March 21, 2013
Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland
Linda Sharp, Lesley Tilson, Sophie Whyte, et al.
European Journal of Heart Failure
|
July 4, 2015
Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study
Mark T Ledwidge, Eoin O'Connell, Joseph Gallagher, et al.
Pharmacoeconomics
|
February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain
Jonathan Briody, Ian S Miller, James F O'Mahony, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 16, 2010
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology
|
August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implications
Brian Godman, William Shrank, Morten Andersen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 1, 2021
Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective
Cormac Kennedy, Laura McCullagh, Roisin Adams, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 2, 2008
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010
Kathleen Bennett, Zubair Kabir, Michael Barry, et al.
British Journal of Clinical Pharmacology
|
December 19, 2014
Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients
Ronan T Grimes, Kathleen Bennett, Lesley Tilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
Joy Leahy, Conor Hickey, David McConnell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2008
Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland
Lesley Tilson, Cara Usher, Karina Butler, et al.
BMC Health Services Research
|
March 21, 2013
Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland
Linda Sharp, Lesley Tilson, Sophie Whyte, et al.
European Journal of Heart Failure
|
July 4, 2015
Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study
Mark T Ledwidge, Eoin O'Connell, Joseph Gallagher, et al.
Pharmacoeconomics
|
February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain
Jonathan Briody, Ian S Miller, James F O'Mahony, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 16, 2010
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology
|
August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implications
Brian Godman, William Shrank, Morten Andersen, et al.
Page
of 3